Remus Pharmaceuticals Limited (NSE:REMUS)
683.50
-0.90 (-0.13%)
At close: Oct 13, 2025
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.